PRQRProQR Therapeutics N.V. Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 20367
Ticker: PRQR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2014-09-18
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PRQR

Detail

Enriched 2026-08-14 20:47

Market cap: $262,485,945.36
Shares outstanding (class): 105,362,551
Shares outstanding (weighted): 141,121,476
SIC: —
Employees: 187
Location: —
Homepage: https://www.proqr.com
Description: ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Market cap and share counts drift.

Funds holding this security

3 funds · 4 positions · $6.40M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
abrdn World Healthcare Fund —	—	$5.37M	1.12%	3,316,965 NS	TICKER
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$1.00M	0.15%	620,000 NS	TICKER
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$11.3K	0.00%	7,000 NS	TICKER
Small Cap Core Fund Northern Funds	—	$7.6K	0.00%	4,690 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERPRQR
CIK0001612940
ISINNL0010872495
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: ProQR Therapeutics is a biopharmaceutical company developing RNA-based therapies, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.